sb 211475 has been researched along with allopurinol in 1 studies
Studies (sb 211475) | Trials (sb 211475) | Recent Studies (post-2010) (sb 211475) | Studies (allopurinol) | Trials (allopurinol) | Recent Studies (post-2010) (allopurinol) |
---|---|---|---|---|---|
6 | 0 | 1 | 15,096 | 743 | 3,363 |
Protein | Taxonomy | sb 211475 (IC50) | allopurinol (IC50) |
---|---|---|---|
Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase | Rattus norvegicus (Norway rat) | 3.3765 | |
Xanthine dehydrogenase/oxidase | Homo sapiens (human) | 3.1861 | |
Xanthine dehydrogenase/oxidase | Bos taurus (cattle) | 5.0758 | |
Histamine H3 receptor | Cavia porcellus (domestic guinea pig) | 8.69 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Feuerstein, GZ; Gu, JL; Lysko, KA; Lysko, PG; Mckenna, PJ; Ruffolo, RR; Yue, TL | 1 |
1 other study(ies) available for sb 211475 and allopurinol
Article | Year |
---|---|
SB 211475, a metabolite of carvedilol, a novel antihypertensive agent, is a potent antioxidant.
Topics: Adenosine Diphosphate; Animals; Antihypertensive Agents; Antioxidants; Ascorbic Acid; Brain; Carbazoles; Cattle; Cell Death; Cells, Cultured; Chromans; Endothelium, Vascular; Fumarates; Humans; Iron; Lipid Peroxidation; Lipoproteins, LDL; Macrophages; Male; Mice; Neurons; Neutrophils; Nicardipine; Oxidation-Reduction; Piperazines; Propanolamines; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Superoxides; Tetradecanoylphorbol Acetate; Xanthine; Xanthine Oxidase; Xanthines | 1994 |